<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04686552</url>
  </required_header>
  <id_info>
    <org_study_id>18-000464</org_study_id>
    <nct_id>NCT04686552</nct_id>
  </id_info>
  <brief_title>Effect Cinnamon Spice on Postprandial Glucose and Insulin Responses</brief_title>
  <acronym>CINNI</acronym>
  <official_title>Effects of Cinnamon Spice on Postprandial Glucose and Insulin in Normal Weight and Obese Individuals With Pre-Diabetes: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the proposed study is to investigate the effect of cinnamon on the&#xD;
      postprandial glycemic response to a high glycemic index meal in normal and overweight/obese&#xD;
      prediabetic subjects&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized crossover study design will be carried out in accordance with the guidelines of&#xD;
      the Human Subjects Protection Committee of the University of California, Los Angeles. All&#xD;
      subjects will give written informed consent before the study begins. There will be two groups&#xD;
      of participants (normal and overweight/obese). Each participant will consume oatmeal prepared&#xD;
      with 1 cup of 2% milk served with or without 6 g of ground cinnamon in random sequence. At&#xD;
      each meal consumption blood will be collected to measure postprandial glucose and insulin at&#xD;
      0, 30, 60, 90, 120, 150 and 180 minutes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">January 1, 2020</completion_date>
  <primary_completion_date type="Actual">January 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>glucose</measure>
    <time_frame>Baseline to 180 minutes</time_frame>
    <description>postprandial glucose reponse</description>
  </primary_outcome>
  <primary_outcome>
    <measure>insulin</measure>
    <time_frame>Baseline to 180 minutes</time_frame>
    <description>postprandial insulin response</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>C-peptide</measure>
    <time_frame>Baseline to 180 minutes</time_frame>
    <description>postprandial C-peptide response</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>glucagon</measure>
    <time_frame>Baseline to 180 minutes</time_frame>
    <description>postprandial glucagon reponse</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lipids</measure>
    <time_frame>Baseline to 180 minutes</time_frame>
    <description>postprandial lipid response</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Normal Weight</condition>
  <condition>Overweight and Obesity</condition>
  <arm_group>
    <arm_group_label>cinnamon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The test meal consisted of ½ cup dry instant oatmeal, prepared with 1 cup of 2% milk served with 6 g of ground cinnamon.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The test meal consisted of ½ cup dry instant oatmeal, prepared with 1 cup of 2% milk served without 6 g of ground cinnamon</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>cinnamon</intervention_name>
    <description>6 g of ground cinnamon</description>
    <arm_group_label>cinnamon</arm_group_label>
    <other_name>control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy human adults age 20-50 years' old&#xD;
&#xD;
          -  Typically consume low fiber/polyphenol diet (beige diet)&#xD;
&#xD;
          -  normal weight individuals with a BMI of 18. to 24.9 kg/ m2 with fasting serum glucose&#xD;
             &lt;100 mg/dL&#xD;
&#xD;
          -  overweight/obese individuals with a BMI of 25 to 35 kg/m2 and fasting serum glucose&#xD;
             ≥100 mg/dL and &lt;126 mg/dL or HbA1c &gt;5.7% and &lt; 6.5%.&#xD;
&#xD;
          -  Subjects must read and sign the Institutional Review Board-approved written informed&#xD;
             consent prior to the initiation of any study specific procedures or enrollment. A&#xD;
             subject will be excluded for any condition that might compromise the ability to give&#xD;
             truly informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any subject with a screening laboratory value outside of the laboratory normal range&#xD;
             that is considered clinically significant for study participation by the investigator.&#xD;
&#xD;
          -  Any subject currently taking blood thinning medications such as Warfarin or Coumadin&#xD;
&#xD;
          -  Any history of gastrointestinal disease or surgery except for appendectomy or&#xD;
             cholecystectomy.&#xD;
&#xD;
          -  Eating a high fiber/polyphenol diet or taking any medication or dietary supplement&#xD;
             which interfere with the absorption of polyphenols.&#xD;
&#xD;
          -  History of gastrointestinal surgery, diabetes mellitus, or other serious medical&#xD;
             condition, such as chronic hepatic or renal disease, bleeding disorder, congestive&#xD;
             heart disease, chronic diarrhea disorders, myocardial infarction, coronary artery&#xD;
             bypass graft, angioplasty within 6 months prior to screening, current diagnosis of&#xD;
             uncontrolled hypertension (defined as systolic BP &gt;160mmHg, diastolic BP &gt;95mmHg),&#xD;
             active or chronic gastrointestinal disorders, bulimia, anorexia, laxative abuse, or&#xD;
             endocrine diseases (except thyroid disease requiring medication) as indicated by&#xD;
             medical history.&#xD;
&#xD;
          -  Pregnant or breastfeeding&#xD;
&#xD;
          -  Currently uses tobacco products.&#xD;
&#xD;
          -  Currently has an alcohol intake &gt; 20 g ⁄ day;&#xD;
&#xD;
          -  Currently has a coffee intake &gt; 3 cups ⁄ day;&#xD;
&#xD;
          -  Allergy or sensitivity to cinnamon. Subjects will be excluded if there is a prior&#xD;
             history of such sensitivity. Since these foods are commonly eaten and allergies are&#xD;
             rare, subjects should be aware of this sensitivity prior to entering the study. To&#xD;
             determine this, a positive history of cinnamon ingestion without incident will be&#xD;
             requested. In addition, any subject with a history of allergy or anaphylaxis of any&#xD;
             kind will be excluded&#xD;
&#xD;
          -  Is lactose intolerant&#xD;
&#xD;
          -  Is unable or unwilling to comply with the study protocol.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhaoping Li, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCLA Center for Human Nutrition</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 21, 2020</study_first_submitted>
  <study_first_submitted_qc>December 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 28, 2020</study_first_posted>
  <last_update_submitted>December 24, 2020</last_update_submitted>
  <last_update_submitted_qc>December 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>Zhaoping Li</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>cinnamon</keyword>
  <keyword>insulin</keyword>
  <keyword>glucose</keyword>
  <keyword>postprandial</keyword>
  <keyword>acute</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

